These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 37301425)

  • 21. Botulinum toxin infiltrations versus local anaesthetic infiltrations in pelvic floor myofascial pain: Multicentre, randomized, double-blind study.
    Levesque A; Ploteau S; Michel F; Siproudhis L; Bautrant E; Eggermont J; Rabischong B; Volteau C; Perrouin-Verbe MA; Labat JJ
    Ann Phys Rehabil Med; 2021 Jan; 64(1):101354. PubMed ID: 31981833
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The use of botulinum toxin in the pelvic floor for women with chronic pelvic pain-a new answer to old problems?
    Abbott J
    J Minim Invasive Gynecol; 2009; 16(2):130-5. PubMed ID: 19167273
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vulvodynia in prepubertal girls: diagnosis.
    Wanczyk-Baszak J; Paszkowski T; Baszak-Radomanska E
    Ginekol Pol; 2022; 93(11):867-871. PubMed ID: 35072227
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnosis and management of vulvodynia in postmenopausal women.
    Vieira-Baptista P; Donders G; Margesson L; Edwards L; Haefner HK; Pérez-López FR
    Maturitas; 2018 Feb; 108():84-94. PubMed ID: 29290220
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gynecological indications for the use of botulinum toxin in women with chronic pelvic pain.
    Abbott J
    Toxicon; 2009 Oct; 54(5):647-53. PubMed ID: 19264089
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictors of Mucosal and Muscle Pain in Vulvodynia: A Cross-Sectional Analysis From the National Vulvodynia Registry.
    Lo L; Lamvu G; Alappattu M; Witzeman K; Markovic D; Rapkin A
    J Pain; 2021 Feb; 22(2):161-170. PubMed ID: 32679255
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of high doses of botulinum toxin A for treating provoked vestibulodynia.
    Pelletier F; Parratte B; Penz S; Moreno JP; Aubin F; Humbert P
    Br J Dermatol; 2011 Mar; 164(3):617-22. PubMed ID: 21275944
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of gabapentin on sexual function in vulvodynia: a randomized, placebo-controlled trial.
    Bachmann GA; Brown CS; Phillips NA; Rawlinson LA; Yu X; Wood R; Foster DC;
    Am J Obstet Gynecol; 2019 Jan; 220(1):89.e1-89.e8. PubMed ID: 30365922
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Botulinum toxin A for the management of vulvodynia.
    Yoon H; Chung WS; Shim BS
    Int J Impot Res; 2007; 19(1):84-7. PubMed ID: 16728964
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Successful treatment of vulvodynia with botulinum toxin A.
    Tieu KD; MacGregor JL
    Arch Dermatol; 2011 Feb; 147(2):251-2. PubMed ID: 21339463
    [No Abstract]   [Full Text] [Related]  

  • 31. Botulinum toxin A injection in the treatment of chronic pelvic pain with hypertonic pelvic floor in women: Treatment techniques and results.
    Chuang FC; Yang TH; Kuo HC
    Low Urin Tract Symptoms; 2021 Jan; 13(1):5-12. PubMed ID: 32654386
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pelvic Floor Muscle Morphometry and Function in Women With Primary and Secondary Provoked Vestibulodynia.
    Fontaine F; Dumoulin C; Bergeron S; Mayrand MH; Khalifé S; Wadell G; Morin M
    J Sex Med; 2018 Aug; 15(8):1149-1157. PubMed ID: 30033191
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Uterine botulinum toxin injections in severe dysmenorrhea, dyspareunia and chronic pelvic pain: Results on quality of life, pain level and medical consumption.
    Martial Kouame J; Levêque C; Siani C; Santos M; Delorme J; Franké O; Amiel C; Bensousan T; Thiers-Bautrant D; Bautrant E
    Eur J Obstet Gynecol Reprod Biol; 2023 Jun; 285():164-169. PubMed ID: 37127000
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improvement in pelvic pain with botulinum toxin type A - Single vs. repeat injections.
    Nesbitt-Hawes EM; Won H; Jarvis SK; Lyons SD; Vancaillie TG; Abbott JA
    Toxicon; 2013 Mar; 63():83-7. PubMed ID: 23220489
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multimodal physical therapy versus topical lidocaine for provoked vestibulodynia: a multicenter, randomized trial.
    Morin M; Dumoulin C; Bergeron S; Mayrand MH; Khalifé S; Waddell G; Dubois MF;
    Am J Obstet Gynecol; 2021 Feb; 224(2):189.e1-189.e12. PubMed ID: 32818475
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Health seeking behaviours and treatments received by Australian women with vulvodynia: A cross-sectional survey.
    Mitchell AM; Armour M; Chalmers KJ
    Aust N Z J Obstet Gynaecol; 2021 Dec; 61(6):927-933. PubMed ID: 34463957
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ischiorectal fossa abscess after pelvic floor injection of botulinum toxin.
    Brueseke TJ; Lane FL
    Am J Obstet Gynecol; 2012 Mar; 206(3):e7-8. PubMed ID: 22381609
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Subjective and objective outcomes of botulinum toxin type A treatment in vestibulodynia: pilot data.
    Brown CS; Glazer HI; Vogt V; Menkes D; Bachmann G
    J Reprod Med; 2006 Aug; 51(8):635-41. PubMed ID: 16967634
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vulvodynia: new concepts and review of the literature.
    Groysman V
    Dermatol Clin; 2010 Oct; 28(4):681-96. PubMed ID: 20883912
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterizing the use of botulinum toxin in patients with Hirschsprung disease treated at referral institutions for pediatric colorectal surgery.
    Rice-Townsend SE; Nicassio L; Glazer D; Avansino J; Durham MM; Calkins CM; Rentea RM; Ralls MW; Wood RJ; Rollins MD; Garvey EM; Lewis KE; Reeder R; Smith CA;
    J Pediatr Surg; 2022 Jun; 57(6):1033-1039. PubMed ID: 35292167
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.